Evoke Pharma Inc
EVOKDelisted Dec 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001403708
Evoke Pharma Inc was delisted on Dec 17, 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Evoke Pharma Inc as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +1 vs. Q1 2024
- Shares held
- 3.15M
- −11.5K (−0.4%) vs. Q1 2024
- Total value
- $1.67M
- −$262.3K (−13.6%) vs. Q1 2024
- New holders
- 4
- 2 more added
- Sold out
- 3
- 1 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVOK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 15 | $2.94M |
| Q2 2025 | 10 | $603.6K |
| Q1 2025 | 10 | $678.2K |
| Q4 2024 | 8 | $965.6K |
| Q3 2024 | 12 | $994.6K |
| Q2 2024 | 16 | $1.67M |
| Q1 2024 | 15 | $1.93M |
| Q4 2023 | 11 | $71.8K |
| Q3 2023 | 11 | $92.4K |
| Q2 2023 | 11 | $97.4K |
| Q1 2023 | 12 | $131.1K |
| Q4 2022 | 12 | $161.2K |
| Q3 2022 | 11 | $117.0K |
| Q2 2022 | 13 | $228.0K |
| Q1 2022 | 22 | $987.0K |
| Q4 2021 | 25 | $1.13M |
| Q3 2021 | 23 | $5.46M |
| Q2 2021 | 22 | $6.17M |
| Q1 2021 | 25 | $7.83M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Evoke Pharma Inc; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 28 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 69 | $37 | 0.00% | +69 | New |
| FMR LLC | 71 | $38 | 0.00% | +71 | New |
| GWM Advisors LLC | 208 | $110 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 375 | $198 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,107 | $586 | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 1,464 | $774 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,479 | $3.96K | 0.00% | +74+1.0% | Added |
| State Street Corp | 10,660 | $5.64K | 0.00% | +10,660 | New |
| Citadel Advisors LLC | 11,911 | $6.30K | 0.00% | +11,911 | New |
| Vanguard Group Inc | 29,851 | $15.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 49,691 | $26.3K | 0.00% | +22,626+83.6% | Added |
| Nantahala Capital Management, LLC | 675,000 | $357.1K | 0.04% | 00.0% | Unchanged |
| Altium Capital Management LP | 692,440 | $366.3K | 0.15% | −32,502−4.5% | Reduced |
| Bleichroeder LP | 825,000 | $436.4K | 0.13% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 846,564 | $447.8K | 0.22% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −13,471−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,869−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −66−100.0% | Sold out |